University of Crete (UOC)
Aρρυθμιογόνες κληρονομικές καρδιοπάθειες στον παιδικό πληθυσμό της νήσου Κρήτης: καταγραφή επίπτωσης και δυνατότητες έγκαιρης ανίχνευσης
Abstract
dc:descriptionIntroduction. Hereditary cardiomyopathies and channelopathies although relatively rare diseases (with a reported prevalence ranging from 1/500 to 1/5000 in the general population, with regional and ethnic variability), they are extremely important due to their associated significant morbidity and mortality, representing the main cause of sudden cardiac death in young people. Their early detection, already from childhood, is extremely important for preventing sudden cardiac death in the affected children and family members. Our current knowledge regarding the epidemiology of arrhythmogenic heart diseases in children is limited, while the implementation and evaluation of screening programs for early detection of cardiovascular diseases (and related risk factors) in the general pediatric population is equally limited. Purpose. The purpose of this study was a) to record the epidemiology of the above diseases in the children's population of Crete and b) to evaluate the possibility of early detection of arrhythmogenic heart disease by the application of a pilot structured screening program for early detection of cardiovascular disease and associated risk factors applied in school age children. Methodology. A. Epidemiology Documentation. The population of the study consisted of pediatric patients < 18 years of age with a permanent place of residence in Crete, evaluated or under follow-up at the Reference Center for Pediatric Cardiology of Pediatric Clinic of Heraklion University Hospital during 23 years (2002-2024), who met the diagnostic criteria for these diseases, with anonymous recording of new diagnoses (incidence) and the total number of diagnosed patients (prevalence) with the above diseases per year. Additionally, information related to age and method of diagnosis, the presence of symptoms, and the underlying etiological diagnosis was recorded. We also recorded the incidence of asymptomatic carriers as additional information. The potential impact of demographic factors including the documentation of regional variation, and differences between the two main categories (cardiomyopathies - channelopathies), were evaluated. Finally, a comparison of the documented incidence in the study population compared to that reported in different ethnic populations was performed. B. Screening program. The screening program for cardiovascular diseases in childhood, performed during this study, evaluated 3rd grade elementary school students (ages 8-9). This program was carried out in local primary health care units of all the geographical regions of Crete, with the informed consent of parents/guardians. The examination included the use of a specifically designed questionnaire on personal and family medical history, a clinical examination with cardiac auscultation, a digital phonocardiogram (PCG) and a standard 12-lead ECG recording. The initial referral indication based on documented responses and initial physical evaluation (Phase I) was further confirmed following a detailed evaluation of the history responses, documentation of the pathological findings of the phonocardiogram and evaluation of the electrocardiogram by an experienced pediatric cardiologist, supported by the use of an electronic health record with diagnostic algorithms (EHR-CDSS) specifically designed for the purposes of the study (Phase II). In the presence of verified reference indication, a final pediatric cardiology evaluation (Phase III) was offered at the Tertiary Reference Center in Crete (academic Pediatric Cardiology Unit, University Hospital Heraklion). Referral indications were recorded as total (in the presence of any referral indication) and individual component related (related to each specific screening tool incorporated to the program), in order to calculate the diagnostic yield of the program and its individual components in the detection of arrhythmogenic heart disease as well as cardiovascular disease and associated risk factors in the population sample studied. The overall diagnostic yield of the pilot application of the screening program was compared to that reported in the literature, while a preliminary cost-effectiveness analysis was performed. Results. Α. Epidemiology. A total number of 98 cases of arrhythmogenic heart disease have been recorded: 81 (82,6%) cases with a documented diagnosis (47 cardiomyopathies, 34 channelopathies), 17 (17,4%) asymptomatic carriers (11 cardiomyopathies, 6 channelopathies). A total of affected children with hypertrophic (28,4%), dilated (24,7%), arrhythmogenic (3,7%) and restrictive (1,2%) cardiomyopathy, long QT syndrome (40,8%), and catecholaminergic paroxysmal ventricular tachycardia (1,2%) were recorded. The average incidence of arrhythmogenic heart disease was estimated at 2,8 new diagnoses per 100.000 children per year (95% C.I: 2,2-3,5), with cardiomyopathies being the most common at 1,6/100.000/year, (95% C.I: 1,2-2,1) followed by channelopathies at 1,2/100.000/year (95% C.I: 0,8-1,6). The overall prevalence was estimated at 49,5 cases/100.000 children (95% C.I.: 37,9–63,4), the prevalence of cardiomyopathies at 25,5 cases/100.000 (95% C.I.: 17,4–36,0), of channelopathies at 23,9 cases/100.000 (95% C.I.: 16,1 – 34,1). Significant regional differences of arrhythmogenic heart disease incidence were recorded. The documented incidence of pediatric cardiomyopathies was increased compared to that reported for pediatric populations of Central European origin, and comparable to that reported for ethnic groups with increased incidence compared to the average in the largest epidemiological studies. A relatively lower prevalence of childhood channelopathy (LQT) documented in our study compared to the majority of international studies could also reflect screening methodology differences between studies. B. Screening program. The population study sample included 977 children (49% boys, mean age of 8,7 years 55% non-urban residence, which voluntary participated. Of them 699 (71,5%) fulfilled at least one initial referral criterion (Phase I). Obesity (10,8%) and hypertension (3,2%) were significantly related to each other (OR 13,4). Verified indication for referral (Phase II) was documented in 327 (33,5%) children (16 with isolated obesity), including abnormal physical evaluation finding (12,4%), verified positive history responses (11,8%) or 12-lead ECG abnormalities ( 7,6%). Of the 201 (61,4%) children who participated in the final diagnostic evaluation (Phase III), the majority (n = 132) were healthy, while in half of the cases (n = 103, 51%) a referral indication to other pediatric subspecialities was established. The final pediatric cardiology evaluation was positive in 69 children (7,1%), with 40 (4,1%) having positive echocardiographic findings (23 children (2,4%) mild findings with follow up indication only, 17 children (1,7%) insignificant findings) and 29 (3%) abnormal ECG findings (23 children (2,4%) non significant with follow up indication only 6 children (0,6%) significant with an indication for further referral to a tertiary pediatric arrhythmia center). One new diagnosis of arrhythmogenic cardiomyopathy (Long QT syndrome) as the first diagnosis in the family (index-case) genetically confirmed in follow up was recorded. Among children with positive findings in the final pediatric cardiology evaluation, three needed treatment and one underwent diagnostic electrophysiological study (0,3 % of the total). The estimated diagnostic yield (in case where all children with referral indication would be evaluated) reaches 11,2% (6,6% echocardiographic findings, 4,6% ECG findings). No diagnostic contribution of the personal/family history was documented in the present study while the all positive echocardiogaphic diagnosis corresponded to referrals for abnormal cardiac auscultation. Similarly, all ECG abnormalities were detected only due to ECG application in the screening program, The diagnostic yield of the preliminary application of the present screening program was within the range reported in the limited available literature, with an estimated cost of testing (all phases) of 10 euros per participant child and 100 euros per positive echocardiographic or ECG based final diagnosis. Conclusions. The present study, represents the first systematic documentation of cardiomyopathies and channelopathies in the pediatric population of the island of Crete, Greece and, to our knowledge, on of the few available for the Mediterranean and European pediatric populations. Furthermore it reports the results of the first cardiac screening program in school-age children in Greece and one of the few available in the literature. The incidence of arrhythmogenic heart diseases in the pediatric population of Crete was increased regarding the cardiomyopathies compared to that reported in the literature for central European origin populations, with significant geographical variations within the island. The pilot application of the screening program of cardiac diseases in 3rd grade students was associated with an estimated diagnostic yield of 11%, based exclusively on experienced cardiac auscultation and accurate pediatric ECG interpretation, with an acceptable cost. The study of epidemiology and the application and validation of dedicated screening programs could be helpful in the early detection, diagnosis and treatment of these rare but life threatening inherited cardiac diseases. Further research is required to document the epidemiology and regional differences of inherited arrhythmogenic cardiac diseases in the pediatric population worldwide and to validate the performance of individual screening tools and their combinations for their early detection, before the general application of pediatric cardiovascular screening programs.
Degree
thesis:*- Grantor dc:publisher
- University of Crete (UOC)
- Year dc:date
- 2025
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Bagkaki, Alena
- Μπαγκάκη, Αλένα
Subjects
dc:subject × 34- Μυοκαρδιοπάθεια
- Διατατική μυοκαρδιοπάθεια
- Υπερτροφική μυοκαρδιοπάθεια
- Αρρυθμιογόνος καρδιομυοπάθεια
- Περιοριστική μυοκαρδιοπάθεια
- Καναλοπάθεια
- Σύνδρομο μακρού QT
- Παιδί
- Κρήτη
- Επιδημιολογία
- Άνιχνευτικό πρόγραμμα
- Καρδιακή ακρόαση
- Ηλεκτροκαρδιογράφημα
- Φωνοκαρδιογράφημα
- Cardiomyopathy
- Dilated cardiomyopathy
- Hypertrophic cardiomyopathy
- Arrhythmogenic cardiomyopathy
- Restrictive cardiomyopathy
- Channelopathy
- Long QT syndrome
- Child
- Crete
- Epidemiology
- Screening program
- Cardiac auscultation
- Electrocardiography
- Phonocardiogram
- Κλινική Ιατρική
- Ιατρική και Επιστήμες Υγείας
- Παιδιατρική, Νεογνολογία και Υγεία του παιδιού
- Clinical Medicine
- Medical and Health Sciences
- Pediatrics, Perinatology and Child Health
Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/59204